Nestlé divests its Palforzia business

By NS Healthcare Staff Writer

05 Sep 23

This agreement follows Nestlé's announcement last year that it would conduct a strategic review of Palforzia

NutraceuticalsR&D (formulation)

Sanofi to acquire US-based health and wellness firm Qunol

By NS Healthcare Staff Writer

31 Jul 23

The acquisition is aimed at bolstering Sanofi's Consumer Healthcare (CHC) division, particularly in the Vitamin, Mineral, and Supplements…

NutraceuticalsOther Ingredients

Solar Biotech Acquires Noblegen

By NS Healthcare Staff Writer

26 Jul 23

Solar Biotech Canada will transform consumer goods to ensure a sustainable future

NutraceuticalsR&D (formulation)

Adare Pharma divests postbiotics unit to dsm-firmenich for €275m

By NS Healthcare Staff Writer

04 Jul 23

Through its B2C division, i-Health, dsm-firmenich plans to increase access to Lactéol, which is the over-the-counter postbiotic supplement…

NutraceuticalsProbiotics

Malteries Soufflet to acquire Australia’s United Malt for $1bn

By NS Healthcare Staff Writer

04 Jul 23

United Malt is a commercial maltster that makes bulk malt for brewers, craft brewers, distillers, and food companies…

NutraceuticalsOther Ingredients

Cipla to purchase nutritional supplement brand Endura Mass

By NS Healthcare Staff Writer

15 Jul 22

Upon completion of the proposed acquisition, which includes Endura brand and all its associated trademarks, CHL intends to…

NutraceuticalsCarbohydrates, Starches and Wheat Glutens

Aceto acquires speciality ingredients manufacturer Biotron

By NS Healthcare Staff Writer

03 Mar 22

The acquisition is expected to expand Aceto’s nutraceuticals capabilities and complements its footprint in the expanding life sciences…

NutraceuticalsOther Ingredients

Sanofi India to sell nutraceuticals business to Universal Nutriscience

By NS Healthcare Staff Writer

29 Jul 21

The sale involves the transfer of Sanofi India’s 16 nutraceutical brands in the portfolio to Universal Nutriscience

NutraceuticalsOther Ingredients

Nestlé to acquire Aimmune Therapeutics in $2.6bn deal

By NS Healthcare Staff Writer

01 Sep 20

Aimmune’s FDA approved Palforzia therapy is expected to expand Nestlé Health Science’s portfolio to reduce the severity of…

Other IngredientsNutraceuticals

Nestlé Health Science agrees to purchase stake in Vital Proteins

By NS Healthcare Staff Writer

11 Jun 20

Vital Proteins will become a part of the Nestlé Health Science portfolio, and will benefit from a variety…

NutraceuticalsOther Ingredients